Index by Author

September 1985; 8 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Adam, D R

    • Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care September 1985 8:436-439; doi:10.2337/diacare.8.5.436

  2. Allen, K

    • Effect of exercise on urinary N-acetyl-beta-D-glucosaminidase activity and albumin excretion in children with type I diabetes mellitus. Diabetes Care September 1985 8:466-472; doi:10.2337/diacare.8.5.466

  3. Alper, C

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

  4. Amore, A

    • An enzyme immunoassay to detect microalbuminuria in diabetic patients. Diabetes Care September 1985 8:525-526

B

  1. Bernstein, R K

    • Two tips for care of diabetic feet. Diabetes Care September 1985 8:525

  2. Bock, A

    • Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus. Diabetes Care September 1985 8:429-435; doi:10.2337/diacare.8.5.429

  3. Brink, S J

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

  4. Brouhard, B H

    • Effect of exercise on urinary N-acetyl-beta-D-glucosaminidase activity and albumin excretion in children with type I diabetes mellitus. Diabetes Care September 1985 8:466-472; doi:10.2337/diacare.8.5.466

  5. Brown, W F

    • Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations. Diabetes Care September 1985 8:447-455; doi:10.2337/diacare.8.5.447

C

  1. Campaigne, B N

    • Effects of exercise training on insulin sensitivity in adolescents with type I diabetes. Diabetes Care September 1985 8:461-465; doi:10.2337/diacare.8.5.461

  2. Canny, C L

    • Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations. Diabetes Care September 1985 8:447-455; doi:10.2337/diacare.8.5.447

  3. Castracane, V D

    • Effect of normoglycemia before conception on early pregnancy hormone profiles. Diabetes Care September 1985 8:473-476; doi:10.2337/diacare.8.5.473

  4. Cerutti, F

    • An enzyme immunoassay to detect microalbuminuria in diabetic patients. Diabetes Care September 1985 8:525-526

  5. Clarke, B F

    • The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care September 1985 8:491-498; doi:10.2337/diacare.8.5.491

  6. Coppo, R

    • An enzyme immunoassay to detect microalbuminuria in diabetic patients. Diabetes Care September 1985 8:525-526

  7. Csima, A

    • Prediction of the relative blood glucose response of mixed meals using the white bread glycemic index. Diabetes Care September 1985 8:418-428; doi:10.2337/diacare.8.5.418

D

  1. Dupre, J

    • Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations. Diabetes Care September 1985 8:447-455; doi:10.2337/diacare.8.5.447

E

  1. Eisenbarth, G S

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

  2. Epstein, L H

    • Compliance to self-monitoring of blood glucose: a marked-item technique compared with self-report. Diabetes Care September 1985 8:456-460; doi:10.2337/diacare.8.5.456

  3. Ewing, D J

    • The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care September 1985 8:491-498; doi:10.2337/diacare.8.5.491

F

  1. Falko, J M

    • Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care September 1985 8:436-439; doi:10.2337/diacare.8.5.436

  2. Fleischnick, E

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

  3. Forland, M

    • The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care September 1985 8:499-506; doi:10.2337/diacare.8.5.499

G

  1. Ganda, O P

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

  2. Greenspan, F S

    • Decreased serum C-peptide/insulin molar ratios after oral glucose in hyperthyroidism. Diabetes Care September 1985 8:524-525

  3. Guidoni, C

    • An enzyme immunoassay to detect microalbuminuria in diabetic patients. Diabetes Care September 1985 8:525-526

H

  1. Hoogwerf, B J

    • Amitriptyline treatment of painful diabetic neuropathy: an inadvertent single-patient clinical trial. Diabetes Care September 1985 8:526-527

  2. Horwitz, D L

    • Aspartame use by persons with diabetes. Diabetes Care September 1985 8:415-417; doi:10.2337/diacare.8.5.415

J

  1. Jackson, R A

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

  2. James, F W

    • Effects of exercise training on insulin sensitivity in adolescents with type I diabetes. Diabetes Care September 1985 8:461-465; doi:10.2337/diacare.8.5.461

  3. Jenkins, D J

    • Prediction of the relative blood glucose response of mixed meals using the white bread glycemic index. Diabetes Care September 1985 8:418-428; doi:10.2337/diacare.8.5.418

  4. Josse, R G

    • Prediction of the relative blood glucose response of mixed meals using the white bread glycemic index. Diabetes Care September 1985 8:418-428; doi:10.2337/diacare.8.5.418

  5. Jovanovic, L

    • Effect of normoglycemia before conception on early pregnancy hormone profiles. Diabetes Care September 1985 8:473-476; doi:10.2337/diacare.8.5.473

K

  1. Kabadi, U M

    • Adjuvant therapy with tolazamide and insulin improves metabolic control in type I diabetes mellitus. Diabetes Care September 1985 8:440-446; doi:10.2337/diacare.8.5.440

  2. Kamath, S

    • Aspartame use by persons with diabetes. Diabetes Care September 1985 8:415-417; doi:10.2337/diacare.8.5.415

  3. Karam, J H

    • Decreased serum C-peptide/insulin molar ratios after oral glucose in hyperthyroidism. Diabetes Care September 1985 8:524-525

  4. Keller, U

    • Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus. Diabetes Care September 1985 8:429-435; doi:10.2337/diacare.8.5.429

  5. Kobe, P

    • Aspartame use by persons with diabetes. Diabetes Care September 1985 8:415-417; doi:10.2337/diacare.8.5.415

  6. Koeske, R

    • Compliance to self-monitoring of blood glucose: a marked-item technique compared with self-report. Diabetes Care September 1985 8:456-460; doi:10.2337/diacare.8.5.456

L

  1. Landt, K W

    • Effects of exercise training on insulin sensitivity in adolescents with type I diabetes. Diabetes Care September 1985 8:461-465; doi:10.2337/diacare.8.5.461

  2. Lee, R

    • Prediction of the relative blood glucose response of mixed meals using the white bread glycemic index. Diabetes Care September 1985 8:418-428; doi:10.2337/diacare.8.5.418

  3. Luqman, W A

    • Periarthritis: another duration-related complication of diabetes mellitus. Diabetes Care September 1985 8:507-510; doi:10.2337/diacare.8.5.507

M

  1. Martyn, C N

    • The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care September 1985 8:491-498; doi:10.2337/diacare.8.5.491

  2. Mazze, R

    • Professional education in a long-term-care facility: program development in diabetes. Diabetes Care September 1985 8:481-485; doi:10.2337/diacare.8.5.481

  3. McIntyre, J

    • Critique of a recent Chemstrip bG/Visidex comparison study. Diabetes Care September 1985 8:520-521

  4. McLane, M P

    • Aspartame use by persons with diabetes. Diabetes Care September 1985 8:415-417; doi:10.2337/diacare.8.5.415

  5. Mills, J L

    • Effect of normoglycemia before conception on early pregnancy hormone profiles. Diabetes Care September 1985 8:473-476; doi:10.2337/diacare.8.5.473

N

  1. Nehrling, J K

    • Aspartame use by persons with diabetes. Diabetes Care September 1985 8:415-417; doi:10.2337/diacare.8.5.415

  2. Nicola, P

    • An enzyme immunoassay to detect microalbuminuria in diabetic patients. Diabetes Care September 1985 8:525-526

  3. Nowalk, M P

    • Compliance to self-monitoring of blood glucose: a marked-item technique compared with self-report. Diabetes Care September 1985 8:456-460; doi:10.2337/diacare.8.5.456

  4. Nuttall, F Q

    • Prediction of the relative blood glucose response of mixed meals using the white bread glycemic index. Diabetes Care September 1985 8:418-428; doi:10.2337/diacare.8.5.418

O

  1. O'Dorisio, T M

    • Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care September 1985 8:436-439; doi:10.2337/diacare.8.5.436

  2. Olson, R E

    • Aspartame use by persons with diabetes. Diabetes Care September 1985 8:415-417; doi:10.2337/diacare.8.5.415

  3. Osei, K

    • Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care September 1985 8:436-439; doi:10.2337/diacare.8.5.436

P

  1. Paisey, R B

    • Diabetic complications. Diabetes Care September 1985 8:521-522

  2. Peled, N

    • Critique of a recent Chemstrip bG/Visidex comparison study. Diabetes Care September 1985 8:520-521

  3. Piccoli, G

    • An enzyme immunoassay to detect microalbuminuria in diabetic patients. Diabetes Care September 1985 8:525-526

Q

  1. Quock, C

    • Decreased serum C-peptide/insulin molar ratios after oral glucose in hyperthyroidism. Diabetes Care September 1985 8:524-525

R

  1. Ra, K

    • Self-reported data: reliability and role in determining program effectiveness. Diabetes Care September 1985 8:486-490; doi:10.2337/diacare.8.5.486

  2. Rizza, R A

    • Combined sulfonylurea and insulin therapy in insulin-dependent diabetes: research or clinical practice? Diabetes Care September 1985 8:511-514

  3. Rodger, N W

    • Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations. Diabetes Care September 1985 8:447-455; doi:10.2337/diacare.8.5.447

  4. Rosenbloom, A L

    • Test strip comparison: Visidex and Chemstrip. Diabetes Care September 1985 8:518-519

  5. Roversi, G D

    • Intensive treatment of diabetes during pregnancy. Diabetes Care September 1985 8:522-523

S

  1. Saitta, M

    • An enzyme immunoassay to detect microalbuminuria in diabetic patients. Diabetes Care September 1985 8:525-526

  2. Sanz, N

    • Decreased serum C-peptide/insulin molar ratios after oral glucose in hyperthyroidism. Diabetes Care September 1985 8:524-525

  3. Sapire, D

    • Effect of exercise on urinary N-acetyl-beta-D-glucosaminidase activity and albumin excretion in children with type I diabetes mellitus. Diabetes Care September 1985 8:466-472; doi:10.2337/diacare.8.5.466

  4. Sattar, M A

    • Periarthritis: another duration-related complication of diabetes mellitus. Diabetes Care September 1985 8:507-510; doi:10.2337/diacare.8.5.507

  5. Scott, N

    • Compliance to self-monitoring of blood glucose: a marked-item technique compared with self-report. Diabetes Care September 1985 8:456-460; doi:10.2337/diacare.8.5.456

  6. Silverstein, J H

    • Test strip comparison: Visidex and Chemstrip. Diabetes Care September 1985 8:518-519

  7. Soeldner, J S

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

  8. Sperling, M A

    • Effects of exercise training on insulin sensitivity in adolescents with type I diabetes. Diabetes Care September 1985 8:461-465; doi:10.2337/diacare.8.5.461

  9. Spinas, G A

    • Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus. Diabetes Care September 1985 8:429-435; doi:10.2337/diacare.8.5.429

  10. Srikanta, S

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

T

  1. Thomas, V L

    • The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care September 1985 8:499-506; doi:10.2337/diacare.8.5.499

  2. Travis, L B

    • Effect of exercise on urinary N-acetyl-beta-D-glucosaminidase activity and albumin excretion in children with type I diabetes mellitus. Diabetes Care September 1985 8:466-472; doi:10.2337/diacare.8.5.466

V

  1. Villeneuve, M

    • Professional education in a long-term-care facility: program development in diabetes. Diabetes Care September 1985 8:481-485; doi:10.2337/diacare.8.5.481

W

  1. Willhoite, B

    • Self-reported data: reliability and role in determining program effectiveness. Diabetes Care September 1985 8:486-490; doi:10.2337/diacare.8.5.486

  2. Wing, R R

    • Compliance to self-monitoring of blood glucose: a marked-item technique compared with self-report. Diabetes Care September 1985 8:456-460; doi:10.2337/diacare.8.5.456

  3. Wolever, T M

    • Prediction of the relative blood glucose response of mixed meals using the white bread glycemic index. Diabetes Care September 1985 8:418-428; doi:10.2337/diacare.8.5.418

  4. Wong, G S

    • Prediction of the relative blood glucose response of mixed meals using the white bread glycemic index. Diabetes Care September 1985 8:418-428; doi:10.2337/diacare.8.5.418

  5. Wylie-Rosett, J

    • Professional education in a long-term-care facility: program development in diabetes. Diabetes Care September 1985 8:481-485; doi:10.2337/diacare.8.5.481

Y

  1. Young, R J

    • The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care September 1985 8:491-498; doi:10.2337/diacare.8.5.491

  2. Yunis, E J

    • Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care September 1985 8:477-480; doi:10.2337/diacare.8.5.477

Z

  1. Zaremba, M M

    • Self-reported data: reliability and role in determining program effectiveness. Diabetes Care September 1985 8:486-490; doi:10.2337/diacare.8.5.486

Current Issue

  1. December 2009, 32 (12)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care